Business Context and Reporting Period
This Form 8-K is filed by iSpecimen Inc. (ISPC) on September 8, 2026. The report addresses a notice from The Nasdaq Stock Market LLC regarding the Company's compliance with listing standards. The Company is an emerging growth company incorporated in Delaware.
Key Financial Metrics and Liquidity
The filing does not provide current revenue, profit, or cash flow figures. However, it references specific financial thresholds and capital raising activities:
- Compliance Threshold: Nasdaq Listing Rule 5550(b) requires a minimum of $2,500,000 in stockholders' equity, or alternatively $35,000,000 in market value of listed securities, or $500,000 in net income from continuing operations.
- Recent Capital Raise: A private placement offering closed on May 11, 2026, generating gross proceeds of approximately $2.5 million.
- Projected Equity: Financial projections submitted to Nasdaq demonstrate stockholders' equity of approximately $5.1 million through June 30, 2027.
Material Changes and Listing Status
On May 29, 2026, Nasdaq notified the Company of non-compliance with the minimum stockholders' equity requirement. Following the submission of compliance plans on July 13, August 6, and September 4, 2026, Nasdaq granted an extension of time to regain compliance.
- Extension Deadline: The Company has until November 25, 2026 to evidence compliance.
- Current Status: The Deficiency Letter has no immediate effect on the listing or trading of the Company's common stock on the Nasdaq Capital Market.
Guidance, Outlook, and Risks
The Company intends to regain compliance within the extension period by evaluating available alternatives, including a planned best-efforts public offering of approximately $5 million in gross proceeds.
Material Risks and Contingencies:
- Delisting Risk: If the Company fails to evidence compliance by the extension deadline or in its next periodic report (for the year ended December 31, 2026), it may be subject to delisting.
- Offering Uncertainty: There is no assurance that the planned public offering will be completed on expected terms, timeline, or at all.
- Compliance Maintenance: Even if compliance is regained, there is no assurance the Company can maintain it.
Investor Verification Checklist
- Verify the status and expected closing date of the planned $5 million best-efforts public offering.
- Monitor the Company's ability to file a report by November 25, 2026 evidencing compliance with the $2.5 million stockholders' equity requirement.
- Review the upcoming periodic report for the year ended December 31, 2026 to confirm continued compliance and avoid delisting.
- Assess the impact of the private placement proceeds ($2.5 million) on the current balance sheet versus the projected $5.1 million equity target.